Safety of morphine in nonintubated infants in the neonatal intensive care unit

Clinical Journal of Pain

Volumn 25, Issue 5, 2009, Pages 418-422

  Taddio, Anna ^a,b   Crosdale, Blondel ^b,c   Hogan, Mary Ellen ^a   El Sayed, Manal F ^b,c   Lee, Kyong Soon ^b,c,d   Moore, Aideen M ^b,c,d   Shah, Vibhuti ^b,d,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c Department of Paediatrics

^d UNIVERSITY OF TORONTO   (Canada)

^e MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Infant newborn; Morphine; Pain management; Respiratory depression; Side effects

Indexed keywords

INOTROPIC AGENT; MORPHINE; NALOXONE; SODIUM CHLORIDE;

ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DRUG OVERDOSE; DRUG SAFETY; FEMALE; GESTATIONAL AGE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN INTENSIVE CARE; OXYGEN SATURATION; OXYGEN THERAPY; PAIN; PERINATAL PERIOD; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROCEDURAL PAIN; RESPIRATION DEPRESSION; SIDE EFFECT; VASCULAR ACCESS;

EID: 67649519542     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e31819b7a3b     Document Type: Article

References (21)

1. Anand KJS, and the International Evidence-based Group for Neonatal Pain. Consensus statement for the prevention and management of pain in the newborn infant. Arch Pediatr Adolesc Med. 2001;155:173-180.
2. American Academy of Pediatrics and Canadian Paediatric Society. Prevention and management of pain and stress in the neonate. Pediatrics. 2000;105:454-461.
3. American Academy of Pediatrics and Canadian Paediatric Society. Prevention and management of pain in the neonate: an update. Pediatrics. 2006;118:2231-2241.
4. Taddio A, Lee C, Yip A, et al. Intravenous morphine and topical tetracaine for treatment of pain in preterm neonates undergoing central line placement. JAMA. 2006;295:793-800.
5. Anand KJS, Hall RW, Desai N, et al. Effects of morphine analgesia in ventilated preterm neonates: primary outcomes from the NEOPAIN randomized trial. Lancet. 2004;363: 1673-1682.
6. Bhandari V, Bergqvist LL, Kronsberg SS, et al, for the NEOPAIN Trial Investigators Group. Morphine administration and short-term pulmonary outcomes among ventilated preterm infants. Pediatrics. 2005;116:352-359.
7. El Sayed MF, Taddio A, Fallah S, et al. Safety profile of morphine following surgery in neonates. J Perinatol. 2007;27: 444-447.
8. Taddio A, Pulleyblank R, McNair C, et al. Survey of opioid utilization for pain management among neonatologists in Canada. Biennial International Forum on Pediatric Pain, White Point Beach, October 2-5, Nova Scotia [abstract]. 2008.
9. Enders J, Gebauer C, Pulzer F, et al. Morphine-related apnoea in CPAP-treated preterm neonates. Acta Paediatr. 2006;95: 1087-1092.
10. Tholl DA, Wager MS, Sajous CH, et al. Morphine use and adverse effects in a neonatal intensive care unit. Am J Hosp Pharm. 1994;51:2801-2803.
11. Pokela ML, Olkkola KT, Seppala T, et al. Age-related morphine kinetics in infants. Dev Pharmacol Ther. 1993;20:26-34.
12. Purcell-Jones G, Dormon F, Sumner E. The use of opioids in neonates. A retrospective study of 933 cases. Anaesthesia. 1987;42:1316-1320.
13. Taketomo CK, Hodding JH, Kraus DM. Pediatric Dosage Handbook. 14th ed. Hudson, OH: Lexi-Comp; 2007-2008:1085.
14. Taddio A. Evidence for systemic morphine and fentanyl analgesia. In: Anand KJS, Stevens BJ, McGrath PJ, eds. Pain in Neonates and Infant. 3rd ed. New York: Elsevier; 2007:141-154.
15. Parshuram CS, To T, Seto W, et al. Systematic evaluation of errors occurring during the preparation of intravenous medication. Can Med Assoc J. 2008;178:42-48.
16. Stevens B, Yamada J, Ohlsson A. Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database Syst Rev. 2004;3:CD001069.
17. Blass EM, Watt LB. Suckling- and sucrose-induced analgesia in human newborns. Pain. 1999;83:611-623.
18. Taddio A, Yiu A, Smith RW, et al. Variability in clinical practice guidelines for sweetening agents in newborn infants undergoing painful procedures. Clin J Pain. 2009;25: 153-155.
19. Hall RW, Kronsberg SS, Barton BA, et al, for the NEOPAIN Trial Investigators Group. Morphine, hypotension, and adverse outcomes among preterm neonates: who's to blame? Secondary results from the NEOPAIN trial. Pediatrics. 2005; 115:1351-1359.
20. Vaillancourt R. Infusion confusion in kids: the need for standard concentrations for paediatric high-alert medications. Can J Hosp Pharm. 2008;61(suppl 1):38-39.
21. Du W, Warrier I, Lehr VT, et al. Changing patterns of drug utilization in a neonatal intensive care population. Am J Perinatol. 2006;23:279-285.